FASEB J.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by ZIMMERMANN, P.
Right arrow Articles by DAVID, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by ZIMMERMANN, P.
Right arrow Articles by DAVID, G.
(The FASEB Journal. 1999;13:S91-S100.)
© 1999 FASEB

The syndecans, tuners of transmembrane signaling

PASCALE ZIMMERMANN and GUIDO DAVID1

Laboratory for Glycobiology and Developmental Genetics, Center for Human Genetics, University of Leuven; and Flanders Interuniversity Institute for Biotechnology, Leuven, Belgium

1Correspondence: Center for Human Genetics, Campus Gasthuisberg, Herestraat 49, B-3000 Leuven, Belgium. E-mail: guido.david{at}med.kuleuven.ac.be


   ABSTRACT
TOP
ABSTRACT
INTRODUCTION
STRUCTURE AND EXPRESSION OF...
FUNCTIONS OF THE SYNDECANS
CONCLUSIONS
REFERENCES
 
Syndecans, a family of transmembrane proteoglycans, are putative integrators of extracellular signals. The interaction of syndecans with extracellular ligands via particular motifs in their heparan sulfate chains, their clustering, association with particular cytoskeletal structures, binding to cytoplasmic effectors, and intracellular phosphorylation represent as many means to bring this role to a successful conclusion. In this review, we will briefly address the characteristics of syndecans as heparan sulfate proteoglycans (HSPGs) and focus mainly on the properties, binding interactions, and potential signaling functions of the cytoplasmic domains of these molecules.—Zimmermann, P., David, G. The syndecans, tuners of transmembrane signaling.


Key Words: focal adhesions • microfilaments • PDZ domains • kinases


   INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
STRUCTURE AND EXPRESSION OF...
FUNCTIONS OF THE SYNDECANS
CONCLUSIONS
REFERENCES
 
MECHANICAL TENSION is critical for the control of cell shape and function. Cell growth, differentiation, apoptosis, motility, signal transduction, and gene expression are modulated by mechanical forces. The way cells sense and respond to mechanical tension, and possibly to microgravity, is far from being fully elucidated. It is clear that there is no single transduction pathway. A broad range of extracellular, membrane, cytoskeletal, and cytoplasmic mediators contribute to mechanical signaling (1-3) , making it essential to consider the whole structural framework that exists in living cells and tissues (4) . The extracellular matrix (ECM)2-adhesion sites-cytoskeleton axis is proposed to play a crucial role. Cells are anchored to the ECM and surrounding cells via specific membrane receptors (integrins, cadherins, selectins, CAMs) that are clustered within adhesion sites (focal adhesion complexes and intercellular complexes) and physically coupled to the tensed cytoskeleton. Cell-generated stresses and external mechanical forces converge on adhesion sites and the transmembrane receptors present in these sites provide molecular supports for the transfer of mechanical signals across the cell surface. The effects of mechanical signals depend on other environmental signals, such as those emanating from growth factors and other ECM molecules. Remarkably, the sensors activated by growth factors are spatially incorporated into focal adhesion complexes. Growth factors, ECM, and mechanical stresses activate the same intracellular signaling cascades and many of the molecules in these pathways are physically immobilized on the cytoskeleton. This may explain how signaling molecules associated with the cytoskeleton change their function when force is applied to the cell surface (4) . No doubt, decoding mechanotransduction promises to be very complex.

Syndecans are transmembrane proteoglycans implicated in several signal transduction cascades that regulate cell proliferation and are also at the cross-section of mechanical signaling, interacting with various effectors of mechanotransduction. Via their extracellular glycosaminoglycan (GAG) chains they bind a multitude of growth factors and ECM molecules. Via their small cytoplasmic domain they interact with the cytoskeleton and potential downstream signal transducers. Therefore, investigators trying to understand the molecular mechanisms of mechanotransduction and perhaps the effect of microgravity will probably deal with the syndecans at some point. In this review, we focus on the properties, binding proteins, and potential functions of the cytoplasmic domain of the syndecans.


   STRUCTURE AND EXPRESSION OF THE SYNDECANS
TOP
ABSTRACT
INTRODUCTION
STRUCTURE AND EXPRESSION OF...
FUNCTIONS OF THE SYNDECANS
CONCLUSIONS
REFERENCES
 
Syndecans are type I membrane proteins that share distinctive structural features (5 , 6 ). In vertebrates, the syndecan family comprises four members (Fig. 1A ). The ectodomains of these molecules display low sequence homology, except for the GAG attachment sites (see below). In contrast, their single membrane-spanning regions and their cytoplasmic domains are highly similar (Fig. 1B ). The cytoplasmic domain of each syndecan has two conserved regions, C1 and C2, respectively proximal and distal to the membrane and common to all syndecans. The C1 and C2 regions are separated by a variable (V) region unique to each syndecan.



View larger version (26K):
[in this window]
[in a new window]
 
Figure 1. (A) Domain organization of the four syndecans (adapted from David, ref. 6 ). GAG, glycosaminoglycan (B) Cytoplasmic sequences of the mammalian syndecans. The variable (V) region, unique to each syndecan, and the conserved (C1 and C2) regions are shown. The postulated interactions of these regions with other components are indicated. Potential phosphorylation sites are underlined and printed in bold. PKC, protein kinase C; PIP2, phosphatidylinositol 4,5-bisphosphate.

Syndecan expression is highly regulated and distinctive patterns of syndecan expression characterize individual cell types, tissues, and developmental stages. Virtually all cell types express at least one form of syndecan, but most express multiple syndecans. As an approximate rule of thumb, syndecan-1 is the major syndecan in epithelial cells, syndecan-2 predominates in fibroblasts, syndecan-3 abounds in neuronal cells, and syndecan-4 is widely expressed. The most dramatic changes in syndecan expression occur during development and are associated with morphological transitions, cell differentiation, or changes in tissue organization. Syndecan expression is also modified in pathological situations, such as wound healing and neoplastic transformation (5-9) .

Syndecans are substituted with long, unbranched polysaccharides of the GAG type. The majority of GAG chains added to syndecan core proteins are heparan sulfate (HS) chains but some of these proteins bear chondroitin sulfate chains as well. After attachment of a tetrasaccharide linkage region to particular serines in these proteins, the biosynthesis of HS chains is achieved by sequential addition of alternating D-N-acetylglucosamine and D-glucuronic acid moieties to the non-reducing end of the growing GAG chain. The number of disaccharides varies from 50 to 150 units. During and after this assembly, individual saccharide units are subjected to a number of enzymatic modifications (reviewed in ref. 10 ). The variability of these modifications along the length of the polymer generates the HS fine structure. This fine structure defines the functional properties of these molecules, since in many cases the binding of a particular ligand to HS depends on a particular pattern of HS modification (reviewed in ref. 11 ). This patterning is highly regulated and characterization of the enzymes responsible for this HS fine structure as well as the elements that encode the patterning is an intensive area of research. It is clear that a particular syndecan can bear differentially modified HS chains depending on cellular origin and developmental stage (see for example ref. 12 ). This adds an additional level of complexity to the structure and versatility of the binding interactions of these proteoglycans.


   FUNCTIONS OF THE SYNDECANS
TOP
ABSTRACT
INTRODUCTION
STRUCTURE AND EXPRESSION OF...
FUNCTIONS OF THE SYNDECANS
CONCLUSIONS
REFERENCES
 
Functions as cell surface HSPGs
Heparan sulfate chains interact with numerous biological effector molecules, including growth factors, growth factor receptors, extracellular matrix proteins, cell-cell adhesion molecules, protease inhibitors, degradative enzymes, proteins involved in lipid metabolism and transport, and pathogens such as viruses, protozoa, and bacteria (5) . As HSPGs, syndecans are thereby implicated in the control of cell proliferation, differentiation, adhesion, and migration, as well as in phenomena like blood coagulation, lipid metabolism, and infection. Nearly all these HS ligands have additional receptors that exhibit a higher degree of binding specificity than the HSPGs and that directly mediate ligand-dependent intracellular activation steps. The genetic evidence that HSPGs are equally important and that the dysregulation of these molecules leads to pathology is compelling. Mice homozygous for a mutant heparan sulfate 2-sulfotransferase gene die as neonates with renal agenesis and skeletal abnormalities (13) . Drosophila N-deacetylase-N-sulfotransferase mutants show wingless- phenotypes (Lin et al., personal communication). How the cell-surface HS operates in these signaling pathways is currently under intense study. This has been particularly well investigated in the case of the activation of tyrosine kinase receptors for the fibroblast growth factor (FGF) family members, mostly bFGF (reviewed in ref. 9 ). Cultured cells fail to respond to this growth factor if they are treated with heparinases, which remove HS, or incubated with chlorates, which block sulfation and thus maturation of the chains. Failure of bFGF to bind and activate the FGF-receptor kinase also occurs in cells that carry mutations in genes encoding enzymes involved in HS biosynthesis. This defect can be rescued if an exogenous source of HS is added, either as soluble molecule or as HS-proteoglycan on adjacent cell surfaces (14) . Different models have been proposed to explain how HSPGs may influence ligand-receptor interaction and signaling (9 , 15-19 ). HSPGs may catalyze the formation of receptor-ligand complexes through allosteric and bridging mechanisms, and affect ligand multimerization and stability. They may influence ligand diffusion and compartmentalization, concentrating ligands close to the signaling receptors at the cell surface, restricting ligands to specific spatial plasma-membrane domains (e.g., basolateral pole, focal adhesions), mediating the endocytosis of the ligands, or sequestering the ligands away from the membrane receptor once shed from the cell surface. Thus, as co-receptors, the syndecans can be essential regulators of primary receptor activation. A more in-depth discussion of this aspect of their function is beyond the scope of this review.

Functions specific to syndecans
As mentioned above, the transmembrane and cytoplasmic regions of syndecans are highly conserved. This strongly suggests that syndecans also play a role in transducing stimuli, provided by extracellular ligand binding, into cytoplasmic signals, or vice versa. Because their cytoplasmic domain is non-catalytic, this could occur by binding to and participating in the organization of cytoskeletal proteins or effectors of intracellular signal transduction cascades. We will review the evidence accumulated in this regard. Often these studies relate only to one particular syndecan, but at least in some cases the conclusions may reasonably be extended to the other members of the family.

Syndecan-1, cell behavior, and microfilament cross-talk
During development, wound repair, or neoplastic transformation, changes in syndecan-1 expression parallel changes in cell behavior (7 , 20 ). Similarly, transfection-induced changes in syndecan-1 expression cause cells to alter their shape, growth, and migration rates as well as their cytoskeletal organization (reviewed in ref. 9 ). More than a decade ago, membrane proteoglycans were proposed to interact specifically with F-actin via their cytoplasmic domains and to provide a transmembrane link by which ECM binding to cell surface HS may control cell shape (21) . Later, syndecan-1 was shown to co-localize with intracellular microfilaments at the basolateral cell surface of mouse mammary epithelial cells (22) .

Subsequent work by Carey and his collaborators on clones of transfected Schwann cells extended this original observation. Clones overexpressing syndecan-1 exhibit enhanced spreading and altered morphology on various substrates, including fibronectin and laminin. This spreading is accompanied by a reorganization of the cytoskeletal structures and the formation of focal adhesions. Patches of cell surface syndecan-1 co-localize with actin during cell spreading but this co-localization is lost when spreading is completed and no stable association of syndecan-1 with focal contacts is observed (23) . This transient co-localization may be due to ligand-mediated clustering of the syndecan, since antibody-induced aggregation of syndecan-1 at the cell surface promotes the co-localization of this proteoglycan with the microfilaments and leads to a reorganization of actin filaments (24) . Antibody-induced syndecan association with microfilaments and effect on microfilament reorganization require the cytoplasmic domain because these properties are lost when syndecan-1 lacks the last 31 carboxy-terminal amino acid residues. Another study shows that deletion of the last 23, but not of the last 11, carboxy-terminal amino acid residues of syndecan-1, as well as the mutation Y to F in the V region of syndecan-1 abolish the co-localization with microfilaments, demonstrating that microfilament association is functionally linked to the V region of syndecan-1 (25) . There is evidence that clustering of syndecan-3 also mediates the association of this syndecan with the microfilament system (9) . It may be noted that the syndecan-1 and syndecan-3 cytoplasmic domains are highly similar (see Fig. 1B ). Whether the V region is sufficient to affect microfilament reorganization was not addressed.

Yet, the cytoplasmic domain is not always implicated in the effects of syndecan-1 on cell behavior. Transfection of syndecan-1 in human Raji lymphoblastoid cells, HS-negative suspension-growing cells, allows the binding and spreading of these cells on thrombospondin, fibronectin, and immobilized antibodies specific for the ectodomain of syndecan-1 core protein. It is surprising to note that syndecan-1 cytoplasmic deletion mutants (lacking the last 12 or 33 amino acid residues) maintain the ability to spread. Nevertheless, spreading is inhibited by cytochalasin D (which blocks actin polymerization) or colchicine (which blocks microtubule polymerization) (26) .

Syndecan-1 is also incriminated in the maintenance of differentiated epithelial morphology, a well-organized actin filament system, and normal growth of epithelial cells (see for example refs. 27-29 ). Re-expression of syndecan-1 in S115 mouse mammary epithelial cells that exhibit a transformed phenotype reestablishes the epithelioid morphology and actin organization of these cells and restricts their tumorigenic growth. However, these effects are not only observed with full-length syndecan-1, but also with syndecan-1 forms that lack the cytoplasmic domain or both the cytoplasmic domain and the transmembrane domain (30) .

Thus, the syndecan-1 cytoplasmic domain can, directly or indirectly, mediate interaction with microfilaments and reorganize microfilaments on clustering of the core protein. Nevertheless, in other instances, syndecan-1 can affect the microfilament system without its cytoplasmic domain. The molecular mechanisms responsible are not known. The expression of the syndecan-1 ectodomain may affect spreading mediated by other transmembrane proteins with cytoskeletal linkages or interfere with FGF signaling.

Syndecan-4, focal adhesions, and protein kinase C (PKC) activation
Woods et al. have shown that two signals are needed to achieve the complete adhesion of primary embryonic fibroblasts to fibronectin (31) . The first signal occurs through integrin binding to the RGD sequence of the cell-binding domain of fibronectin. This promotes attachment and spreading. The second signal is mediated by the heparin-binding activity of fibronectin and allows the formation of focal adhesions and stress fibers. This activity is mainly contained in the PRARI peptide sequence of the carboxy-terminal heparin-binding domain of fibronectin. The biological response to this domain seems to be mediated by cell membrane heparan sulfate proteoglycans because treatment of the cells with heparinase significantly inhibits stimulation of focal adhesion formation (32) . The observation that syndecan-4 is enriched in and co-distributes with integrins in focal adhesions of many different cell types adhering to various ECM proteins (33) led to the proposal that syndecan-4 mediates focal adhesion and stress-fiber formation. The response to the second signal can also be obtained by stimulation of the cells with phorbol esters (34) , indicating that one potential downstream effect of HSPGs is the activation of PKC. On activation and translocation to distinct intracellular sites, PKC isozymes (35) participate in many different agonist-induced signaling cascades and may be important regulators of cytoskeletal function (36) . PKC{alpha} has been localized to focal adhesions of normal but not transformed fibroblasts (37) and inhibition of PKC correlates with a lack of focal adhesion formation (34) . Couchman and collaborators further investigated a possible link between PKC and syndecan-4. They showed that syndecan-4, via its V region, can interact with the catalytic domain of PKC and stimulate its activity. Neither the V region of syndecan-2 nor that of syndecan-1 is effective (38) . PKC activation was directly correlated to the level of oligomerization of syndecan-4, in particular the V region (39) . Dimerization is not sufficient for PKC regulatory activity, whereas octamers are more active than tetramers. This indicates that clustering of syndecan-4, in response to extracellular ligand binding in vivo, may control the signaling event (39) . In addition to PKC, the syndecan-4 V region binds phosphatidylinositol 4,5-bisphosphate (PIP2) (39-41) . PIP2 is an important component of several intracellular signaling pathways (42) . It regulates the function of a number of actin binding proteins and is a substrate for phospholipase C. PIP2 also activates PKC by binding to its regulatory domain (43) and stimulates the translocation of PKC from the soluble to the particulate fraction (44) . The syndecan-4 V region further potentiates PKC activity induced by PIP2, and PIP2 is able to induce higher-order oligomeric structures of the syndecan-4 V region. During cell adhesion, clustering of integrins activates phosphatidylinositol 4-phosphate 5-kinase, resulting in the accumulation of PIP2. All this suggests that PKC, PIP2, and the syndecan-4 V region can form a ternary complex that both localizes PKC to assembling focal adhesions and potentiates PKC activity (45) .

On the other hand, in serum-starved primary chicken embryo fibroblasts cultured on native fibronectin, syndecan-4 localizes poorly to focal adhesions, but activation of PKC by serum or 12-O-tetradecanoyl phorbol 13-acetate (TPA) induces the active recruitment of syndecan-4 to focal adhesions (46) . The TPA-induced association of syndecan-4 to focal adhesions increases with time and is more evident with mature focal adhesions than with the newly forming ones, suggesting that it represents a late event during adhesion. The association of syndecan-4 with focal adhesions correlates also with fibronectin deposition. Thus, the syndecan-4 core protein can be part of focal adhesion complexes but it is not clear if syndecan-4 is required for focal-adhesion formation or recruited to focal adhesions under certain conditions.

The conserved cytoplasmic region 1 (C1 region) of the syndecans interacts with members of the src/cortactin signaling pathway and tubulin
Heparin-binding growth factor-associated molecule (HB-GAM/pleiotrophin) is a matrix- and cell surface-associated protein that promotes neurite outgrowth. Syndecan-3 is a cell-surface receptor for HB-GAM and is implicated in the activity of this molecule on neurite outgrowth (47-49) . HB-GAM interacts with the heparan sulfate chains of syndecan-3 (50) . HB-GAM-dependent neurite outgrowth in syndecan-3-transfected cells is inhibited by the tyrosine kinase inhibitor herbimycin A and by PP1, a selective inhibitor of the Src family kinases (49) . When the cytoplasmic domain of syndecan-3 is immobilized and used for affinity isolation, a set of proteins including c-src and Fyn kinases, cortactin, tubulin, and an unidentified 30-kDa protein are eluted from the column (49) . All the binding components can be displaced with a full-length syndecan-3 cytosolic peptide, but also with a peptide corresponding to the C1 region, suggesting that these components are binding candidates for all the members of the syndecan family. However, when the binding components are separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and binding is analyzed by overlaying with a labeled cytosolic peptide of syndecan-3, only the 30-kDa polypeptide is highlighted. This suggests that, except for the 30-kDa protein, these components bind indirectly. Significantly, syndecan-3-transfected cells grown on HB-GAM show enhanced phosphorylation of c-src and cortactin. Cortactin has been identified as a microfilament binding protein and as a major substrate for v-src (51) . Src-induced tyrosine phosphorylation of cortactin results in a decreased ability of cortactin to cross-link actin (52) . Cortactin redistributes to the cell periphery with F-actin on src activation (53) . Src family kinases have been implicated in many cellular events where syndecans also have a role, like cell adhesion and spreading, focal adhesion formation, cell migration, and FGF receptor signaling (54) . Thus, interaction with Src family kinases potentially offers a mechanism for syndecans to regulate these biological events. The fact that tubulin was detected among the binding proteins of the cytosolic peptide is also suggestive for a crosstalk between syndecans and microtubules.

The conserved cytoplasmic region 2 (C2 region) of the syndecans interacts with the PDZ proteins, syntenin and hCASK
In yeast two-hybrid screens, two binding proteins for the C2 (FYA) region of syndecans have been identified. Both interact with syndecans via their PDZ domains. PDZ domains are evolutionarily conserved protein-protein binding modules, originally identified in membrane-associated guanylate kinase homologs (MAGUKs). They have been shown to be widespread among signaling and cytoskeletal proteins (55) . PDZ domains are globular domains binding to and discriminating between short carboxy-terminal motifs of three to four residues. Some PDZ domains appear to bind many targets and, conversely, some targets bind several different PDZ proteins. PDZ domains have also been shown to bind to other PDZ domains, and in one case to an internal (STV) motif (56) . PDZ domains are involved in the organization of cytoskeletal and signaling networks, the clustering of transmembrane receptors, the targeting of particular proteins to specific subcellular regions, and the promotion of interactions with cellular substrates (56, and references therein).

The first PDZ-protein identified to bind the syndecan C2 region, syntenin, is a novel protein. Syntenin is widely expressed and consists of 298 amino acids and can be divided in at least three subdomains (57) . The amino-terminal region (aa 1–109) contains one potential SH3-binding motif (PXXP), tyrosine residues that on phosphorylation potentially constitute recognition sequences for SH2 domains, and several serines and threonines. The amino-terminal region is followed by two PDZ domains in tandem (aa 110–193 and aa 194–274) that seem both necessary and sufficient for the binding to syndecans. Recombinant enhanced green fluorescent protein (eGFP)-syntenin fusion proteins decorate the plasma membrane and co-cluster with overexpressed syndecans. Cells overexpressing eGFP-syntenin show numerous cell surface extensions, suggesting effects of syntenin on cytoskeleton-membrane organization. Syntenin has no obvious catalytic domain and therefore is unlikely to have a signaling function by itself but, because of its structure, it could attach syndecans to signaling components and to the cytoskeleton. The stoichiometry of the syndecan-syntenin binding remains to be clarified. The requirement of coupled PDZ domains and the failure of syntenin to bind free peptide suggests that the syntenin-syndecan interaction may require a prior dimerization or clustering of the syndecans. In addition, it is not clear whether syndecans bind both PDZ pockets in syntenin or if one pocket could remain available for the carboxy-terminal end of another membrane receptor or cytosolic protein.

A second PDZ protein interacting with the syndecan C2 region is hCASK (58 , 59 ). CASK is a member of the MAGUK family. It contains an amino-terminal calcium-calmodulin-dependent protein kinase-like domain, a PDZ domain (responsible for the binding to syndecans), an SH3 domain, a protein 4.1 binding motif, and a domain homologous to guanylate kinase. CASK represents the human ortholog of the C. elegans LIN-2 protein. LIN-2 is required to localize the LET-23 receptor tyrosine kinase to the basal membrane domain where it can respond to the LIN-3/EGF-like ligand and induce a Ras/MAP kinase signaling pathway required for cell fate determination during vulval cell differentiation (reviewed in ref. 60 ). CASK is expressed in all human tissues tested so far and localizes to basal, lateral, or basolateral plasma membrane domains in different epithelial cell types in rat tissue sections. CASK shows overlapping distribution with syndecan-1 in sections of different mouse epithelial tissues (58) and with syndecan-2 in rat brain sections (59) . Thus, syndecan-CASK interaction could be implicated in the basolateral distribution of syndecans in epithelial cells. Indeed, the C2 and/or V region(s) of syndecan-1 is/are required for the steady-state basolateral distribution of this proteoglycan in Madin-Darby canine kidney cells (61) . In vitro binding experiments indicate that CASK also interacts with the actin/spectrin-binding protein 4.1. This raises the possibility that CASK can bind to other members of this protein family such as ezrin, radixin, moesin, merlin, or talin, which are implicated in the organization of the cortical actin cytoskeleton (62) . By extension, syndecans could be connected to the cortical actin network via CASK. In that case, this would represent a path that connects syndecans and actin that differs from the one described in Carey et al. (25) , where the V, and not the C2, region is responsible for the aggregation of syndecan-1 along stress fibers.

The transmembrane–cytoplasmic domain of syndecans and internalization of extracellular ligands
Williams and collaborators, studying the role of HSPGs in lipoprotein catabolism, showed that transfection of Chinese hamster ovary cells with expression vectors encoding syndecans, increased the binding and degradation of lipoproteins enriched in lipoprotein lipase, a heparin-binding protein (63) . In addition, they provided strong evidence that, upon clustering, the transmembrane and cytoplasmic domains of syndecans mediate the internalization of extracellular bound ligands. In particular, they showed that IgG-mediated clustering of a chimeric receptor that consists of the ectodomain of the IgG Fc receptor Ia fused to the transmembrane and cytoplasmic domains of syndecan-1 initiates receptor internalization via a non-coated pit pathway (63) . Ligand internalization provides additional means for syndecans to regulate signaling events.

Oligomerization, a prerequisite for syndecan signaling?
Deglycanated syndecans migrate aberrantly during electrophoresis in SDS-polyacrylamide gels. This has been attributed to the formation of non-covalently linked SDS-resistant dimers and higher-order oligomers (5) . Deglycanated syndecan-2, for example, migrates as bands of 48 and 90 kDa, corresponding to approximately two and four times the predicted Mr of the protein, and re-runs as a mixture of 48- and 90-kDa bands after separate elution and re-electrophoresis of the initial individual bands (our own unpublished observation). Ligand-induced dimerization or oligomerization is a key event in signaling via transmembrane receptors, and the intrinsic propensity of syndecans to self-associate may be significant in this respect.

Asundi and Carey (64) have demonstrated that syndecan-3 core protein oligomerization does not require the cytoplasmic domain, but the transmembrane domain and ectodomain. The oligomerization appears to be mediated by intermolecular interdigitation of bulky and small side chains of amino acid residues in the amino-terminal half of the transmembrane domain, and by electrostatic interactions between four extracellular juxtamembranar charged amino acid residues. Preliminary data, indicating that dimerization-deficient forms of syndecan-3 do not colocalize with actin filaments after antibody-mediated clustering in transfected Schwann cells (9) , may impart physiological significance to these findings. The extent to which self-association via this mechanism is shared by all syndecans was not fully addressed, but syndecan-1 core protein did not oligomerize under similar conditions, whereas syndecan-2 and -4 lack a presumably crucial basic residue in their ectodomain.

Yet, glutathion-S-transferase fused to syndecan-2 or syndecan-4 from which the cytoplasmic domain has been deleted also migrates with Mr much greater than predicted, confirming the formation of SDS-resistant oligomers and further documenting that the cytoplasmic domain is not essential or solely responsible for self-association (39 , 65 ). In addition, the cytoplasmic domain on its own can also multimerize. Peptide corresponding to the complete syndecan-2 cytoplasmic domain is able to dimerize in vitro and this dimerization influences the extent of the phosphorylation of this peptide by PKC (65) . As discussed above, the degree of oligomerization of syndecan-4 V region correlates with the effect on PKC activity. Interaction of syndecans with syntenin seems to necessitate multimerization of syndecans. Thus, syndecan multimerization, which may be driven by different mechanisms and via different subregions, seems associated with cytoskeletal interaction and signaling.

Do natural ligands mediate syndecan oligomerization? Adding soluble lipoprotein lipase and bFGF to cultured fibroblasts induces a redistribution and alignment of the syndecans with the microfilament system (66) , and adding beads coated with bFGF or type I collagen to syndecan-1-expressing Schwann cells results in the clustering of syndecan-1 at the cell/bead interface and recruitment of actin filaments (9) .

Phosphorylation of the cytoplasmic domain of the syndecans
Phosphorylation events are often crucial in the propagation of intracellular signals. The cytoplasmic domain of the syndecans contains three conserved tyrosines, one conserved serine, and various non-conserved serine/threonines that may serve as phosphorylation sites (Fig. 1B ). These include consensus sequences for PKA, PKC, PKG, and calcium-calmodulin-dependent protein kinase II. Among the conserved tyrosines, two are in a favorable context to be phosphorylated (67-69) . One is located in the C1 region within the sequence DEGSY, the other in the C2 region within the sequence EFYA. This has led to the speculation that phosphorylation is a means of regulation. By analogy with other systems, tyrosine phosphorylation of the syndecan cytoplasmic domains may provide docking sites for proteins containing SH2 domains and promote the assembly of signaling complexes at the cell surface. Although various groups reported that syndecans can be phosphorylated on their cytoplasmic domain, the physiological significance of the identified phosphorylations is still not known.

Syndecan-3 tyrosine phosphorylation has been demonstrated in bacteria expressing Elk kinase (70) . Syndecan-1 tyrosine phosphorylation has been reported in vivo after treatment of cells with pervanadate, a potent inhibitor of tyrosine phosphatases and activator of cellular tyrosine kinases that are normally retained in inactive forms by dephosphorylation. It is interesting to note that pervanadate also induces shedding of the syndecan-1 ectodomain into the medium, presumably by activation of a membrane protease via intracellular signaling. Tyrosine phosphorylation-independent shedding of syndecan-1 can be induced by PKC activation (71) . Most cells have only very low steady-state levels of syndecan-tyrosine phosphorylation but constitutive tyrosine phosphorylation of the cytoplasmic domain of the syndecans occurs in adherent B82 fibroblasts (Ott and Rapraeger, personal communication).

In vitro assays with PKCß have shown that, among the 13 serines and threonines available in the four syndecan cytoplasmic domains, only syndecan-2 S197 (GERKPSSAA) and syndecan-3 S339 (EEPKQASVT) could be phosphorylated by this enzyme (72) . In vitro experiments by Oh et al. (64) identified S197 and S198 of syndecan-2 as residues that can be phosphorylated by PKC{alpha}ß{gamma}. They also showed that the extent of phosphorylation varied with the oligomerization state of this substrate. Syndecan-2 cytoplasmic domain serine phosphorylation has also been reported in vivo in mouse lung carcinoma cells (73) . Horowitz and Simons (74) observed that approximately one-third of syndecan-4 S183 is phosphorylated in growth-arrested NIH 3T3 fibroblasts. This phosphorylation is increased by phorbol myristate acetate treatment and decreased by bFGF. Based on the effect of different inhibitors, the authors concluded that phosphorylation of this serine residue is controlled by a nPKC isozyme and a bFGF-dependent serine/threonine phosphatase type 1 or 2A. This serine is part of a conserved seven-residue sequence (KKDEGSY) in the C1 region and these findings may thus be relevant to all four members of the syndecan family.


   CONCLUSIONS
TOP
ABSTRACT
INTRODUCTION
STRUCTURE AND EXPRESSION OF...
FUNCTIONS OF THE SYNDECANS
CONCLUSIONS
REFERENCES
 
HSPGs have profound effects on cell behavior. So far the biological effects of HSPGs have mostly been attributed to the properties of their HS chains. These properties depend on the activity of numerous HS-modifying enzymes, which in turn depends on cell context. These chains modulate the effect of growth factors and adhesion molecules. The cloning of the syndecans, a family of proteoglycans with highly conserved transmembrane and cytoplasmic domains, suggests that in addition to bearing HS, the cell-surface HSPGs also have a more direct role in transducing extracellular stimuli into cytoplasmic signals. Clustering of the syndecans probably represents an important step in signaling events. Figure 1B summarizes the molecular links that are established so far between the cytoplasmic domains of the syndecans and intracellular kinases, phospholipids, adaptor proteins, and cytoskeletal proteins. Nevertheless, the exact role(s) of each of these domains remains far from obvious. The C1 and C2 regions likely fulfill common roles, whereas the V region probably serves a unique function. Further experiments will probably establish additional links between the cytoplasmic domain of syndecans and intracellular molecules. The challenge is now in defining the experiments that should establish the functional relevance of the interaction of syndecans with their cytoplasmic partners.

Concerning a possible sensitivity of syndecan functions to microgravity, the debate is now open. Both the cytoskeleton and intracellular signal transduction, in particular PKC pathways, are modified in microgravity (75-79) . The link between syndecans and these systems has been clearly documented above. Obviously, the role of syndecan-4 in focal adhesion formation and in PKC activation is of special interest in this respect. But are the small changes, in terms of energy, that occur in microgravity likely to have any effect on this syndecan function? The importance of syndecan oligomerization for most syndecan-signaling pathways suggests this step or the tethering of cytoplasmic molecules to the oligomerized cytoplasmic domains could be a privileged target. Syndecan oligomerization is probably dependent on the neutralization by ligand of the highly negative charges, present in HS chains, for which it is difficult to imagine any effect of microgravity, unless the actual signaling form of the syndecans consists of the sole transmembrane and cytoplasmic domains severed from the ectodomain as a result of proteolytic cleavage (shedding). Although receptor processing is part of other signaling systems, for syndecans this remains an unexplored possibility.


   ACKNOWLEDGMENTS
 
We thank Prof. C. Lapière, Dr. B. Van der Schueren, Dr. J. Dürr, Dr. P. Cuppers, Dr. W. Annaert, and Dr. M. Petit for comments on the manuscript. This work was supported by the Fonds voor Wetenschappelijk Onderzoek-Vlaanderen, the Geconcerteerde Onderzoeksacties 1996-2000, the Interuniversity Network for Fundamental Research sponsored by the Belgian Government, and the Flanders Interuniversity Institute for Biotechnology. G. D. is a Research Director of the Fonds voor Wetenschappelijk Onderzoek-Vlaanderen.


   FOOTNOTES
 
2 Abbreviations: HSPGs, heparan sulfate proteoglycans; ECM, extracellular matrix; GAG, glycosaminoglycan; HS, heparan sulfate; FGF, fibroblast growth factor; PKC, protein kinase C; PIP2, phosphatidylinositol 4,5-bisphosphate; TPA, 12-O-tetradecanoyl phorbol 13-acetate; HB-GAM, heparin-binding growth factor-associated molecule; MAGUKs, membrane-associated guanylate kinase homologs; SDS-PAGE, sodium dodecyl sulfate-polyacrylamide gel electrophoresis.


   REFERENCES
TOP
ABSTRACT
INTRODUCTION
STRUCTURE AND EXPRESSION OF...
FUNCTIONS OF THE SYNDECANS
CONCLUSIONS
REFERENCES
 

  1. Ingber, D. (1991) Integrins as mechanochemical transducers. Curr. Opin. Cell Biol. 3,841-848[Medline]
  2. Duncan, R. L., Turner, C. H. (1995) Mechanotransduction and the functional response of bone to mechanical strain. Calcif. Tissue Int. 57,344-358[Medline]
  3. Tavernarakis, N., Driscoll, M. (1997) Molecular modeling of mechanotransduction in the nematode Caenorhabditis elegans. Annu. Rev. Physiol. 59,659-689[Medline]
  4. Ingber, D. (1997) Tensegrity: the architectural basis of cellular mechanotransduction. Annu. Rev. Physiol. 59,575-599[Medline]
  5. Bernfield, M., Kokenyesi, R., Kato, M., Hinkes, M. T., Spring, J., Gallo, R. L., Lose, E. J. (1992) Biology of the syndecans. Annu. Rev. Cell Biol. 8,365-393
  6. David, G. (1993) Integral membrane heparan sulfate proteoglycans. FASEB J 7,1023-1030[Abstract]
  7. Bernfield, M., Hinkes, M. T., Gallo, L. (1993) Developmental expression of the syndecans: possible function and regulation. Dev. Suppl. ,205-212
  8. Kim, C. W., Goldberger, O. A., Gallo, R. L., Bernfield, M. (1994) Members of the syndecan family of heparan sulfate proteoglycans are expressed in distinct cell-, tissue-, and development-specific patterns. Mol. Biol. Cell 5,797-805[Abstract]
  9. Carey, D. J. (1997) Syndecans: multifunctional cell-surface co-receptors. Biochem. J. 327,1-16
  10. Habuchi, H., Habuchi, O., Kimata, K. (1998) Biosynthesis of heparan sulfate and heparin. How are the multifunctional glycosaminoglycans built up?. Trends Glycosci. Glycotechnol. 10,65-80
  11. Lyon, M., Gallagher, J. T. (1998) Bio-specific sequences and domains in heparan sulphate and the regulation of cell growth and adhesion. Matrix Biol. 17,485-493[Medline]
  12. Sanderson, R. D., Turnbull, J. E., Gallagher, J. T., Lander, A. D. (1994) Fine structure of heparan sulfate regulates syndecan-1 function and cell behavior. J. Biol. Chem. 269,13100-13106[Abstract/Free Full Text]
  13. Bullock, S. L., Fletcher, J. M., Beddington, R. S. P., Wilson, V. A. (1998) Renal agenesis in mice homozygous for a gene trap mutation in the gene encoding heparan sulfate 2-sulfotransferase. Genes Dev 12,1894-1906[Abstract/Free Full Text]
  14. Filla, M., Dam, P., Rapraeger, A. C. (1998) The cell surface proteoglycan syndecan-1 mediates specific FGF-2 binding and activity. J. Cell Physiol. 174,310-321[Medline]
  15. Lander, A. D. (1998) Proteoglycans: Master regulators of molecular encounter?. Matrix Biol. 17,465-472[Medline]
  16. Yanagishita, M. (1998) Cellular catabolism of heparan sulfate proteoglycans. Trends Glycosci. Glycotechnol. 10,57-63
  17. Reiland, J., Rapraeger, A. C. (1993) Heparan sulfate proteoglycan and FGF receptor target basic FGF to different intracellular destinations. J. Cell Sci. 105,1085-1093[Abstract]
  18. Subramanian, S. V., Fitzgerald, M. L., Bernfield, M. (1997) Regulated shedding of syndecan-1 and -4 ectodomain by thrombin and growth factor receptor activation. J. Biol. Chem. 272,14713-14720[Abstract/Free Full Text]
  19. Steinfeld, R., Van Den Berghe, H., David, G. (1996) Stimulation of fibroblast growth factor receptor-1 occupancy and signaling by cell surface-associated syndecans and glypican. J. Cell Biol. 133,405-416[Abstract/Free Full Text]
  20. Inki, P., Joensuu, R., Grenman, R., Klemi, P., Jalkanen, M. (1994) Association between syndecan-1 expression and clinical outcome in squamous cell carcinoma of the head and neck. Br. J. Cancer 70,319-323[Medline]
  21. Rapraeger, A. C., and Bernfield, M. (1982) An integral membrane proteoglycan is capable of binding components of the cytoskeleton and the extracellular matrix. In Extracellular Matrix (Hawkes, S., and Wang, J., eds) pp. 265–269, Academic Press, New York
  22. Rapraeger, A. C., Jalkanen, M., Bernfield, M. (1986) Cell surface proteoglycan associates with the cytoskeleton at the basolateral cell surface of mouse mammary epithelial cells. J. Cell Biol. 103,2683-2696[Abstract/Free Full Text]
  23. Carey, D. J., Stahl, R. C., Cizmeci-Smith, G., Asundi, V. K. (1994) Syndecan-1 expressed in Schwann cells causes morphological transformation and cytoskeletal reorganization and associates with actin during cell spreading. J. Cell Biol. 124,161-170[Abstract/Free Full Text]
  24. Carey, D. J., Stahl, R. C., Tucker, B., Bendt, K. A., Cizmeci-Smith, G. (1994) Aggregation-induced association of syndecan-1 with microfilaments mediated by the cytoplasmic domain. Exp. Cell Res. 214,12-21[Medline]
  25. Carey, D. J., Bendt, K. M., Stahl, R. C. (1996) The cytoplasmic domain of syndecan-1 is required for cytoskeleton association but not detergent insolubility. J. Biol. Chem. 271,15253-15260[Abstract/Free Full Text]
  26. Lebakken, C. S., Rapraeger, A. C. (1996) Syndecan-1 mediates cell spreading in transfected human lymphoblastoid (Raji) cells. J. Cell Biol. 132,1209-1221[Abstract/Free Full Text]
  27. Leppa, S., Mali, M., Miettinen, H. M., Jalkanen, M. (1992) Syndecan expression regulates cell morphology and growth of mouse mammary epithelial tumor cells. Proc. Natl. Acad. Sci. USA 89,932-936[Abstract/Free Full Text]
  28. Kato, M., Saunders, S., Nguyen, H., Bernfield, M. (1995) Loss of cell surface syndecan-1 causes epithelia to transform into anchorage-independent mesenchyme-like cells. Mol. Biol. Cell 6,559-576[Abstract]
  29. Sun, D., McAlmon, K. R., Davies, J. A., Bernfield, M., Hay, E. D. (1998) Simultaneous loss of expression of syndecan-1 and E-cadherin in the embryonic palate during epithelial-mesenchymal transformation. Int. J. Dev. Biol. 42,733-736[Medline]
  30. Mali, M., Andtfolk, H., Miettinen, H. M., Jalkanen, M. (1994) Suppression of tumor cell growth by syndecan-1 ectodomain. J. Biol. Chem. 269,27795-27798[Abstract/Free Full Text]
  31. Woods, A., Couchman, J. R., Johansson, S., Hook, M. (1986) Adhesion and cytoskeletal organisation of fibroblasts in response to fibronectin fragments. EMBO J 5,665-670[Medline]
  32. Woods, A., McCarthy, J. B., Furcht, L. T., Couchman, J. R. (1993) A synthetic peptide from the COOH-terminal heparin-binding domain of fibronectin promotes focal adhesion formation. Mol. Biol. Cell 6,605-613
  33. Woods, A., Couchman, J. R. (1994) Syndecan-4 heparan sulfate proteoglycan is a selectively enriched and widespread focal adhesion component. Mol. Biol. Cell 5,183-192[Abstract]
  34. Woods, A., Couchman, J. R. (1992) Protein kinase C involvement in focal adhesion formation. J. Cell Sci. 101,277-290[Abstract/Free Full Text]
  35. Mochly-Rosen, D., Gordon, A. S. (1998) Anchoring proteins for protein kinase C: a means for isozyme selectivity. FASEB J 12,35-42[Abstract/Free Full Text]
  36. Keenan, C., Kelleher, D. (1998) Protein kinase C and the cytoskeleton. Cell. Signal. 10,225-232[Medline]
  37. Hyatt, S. L., Klauck, T., Jaken, S. (1990) Protein kinase C is localized in focal contacts of normal but not transformed cells. Mol. Carcinogen. 3,45-53[Medline]
  38. Oh, E.-S., Couchman, J. R., Woods, A. (1997) Syndecan-4 proteoglycan regulates the distribution and activity of protein kinase C. J. Biol. Chem. 272,8133-8136[Abstract/Free Full Text]
  39. Oh, E.-S., Couchman, J. R., Woods, A. (1997) Multimerization of the cytoplasmic domain of syndecan-4 is required for its ability to activate protein kinase C. J. Biol. Chem. 272,11805-11811[Abstract/Free Full Text]
  40. Oh, E.-S., Woods, A., Lim, S.-T., Theibert, A. W., Couchman, J. R. (1998) Syndecan-4 proteoglycan cytoplasmic domain and phosphatidylinositol 4,5-bisphosphate coordinately regulate protein kinase C activity. J. Biol. Chem. 273,10624-10629[Abstract/Free Full Text]
  41. Lee, D., Oh, E.-S., Woods, A., Couchman, J. R., Lee, W. (1998) Solution structure of a syndecan-4 cytoplasmic domain and its interaction with phosphatidylinositol 4,5-bisphosphate. J. Biol. Chem. 273,13022-13029[Abstract/Free Full Text]
  42. Lee, S. B., Rhee, S. G. (1995) Significance of PIP2 hydrolysis and regulation of phospholipase C isozymes. Curr. Opin. Cell Biol. 7,183-189[Medline]
  43. Pap, E. H. W., Bastiaens, P. I. H., Borst, J. W., van den Berg, P. A. W., van Hoek, A., Snoek, G. T., Wirtz, K. W. A., Visser, A. J. W. G. (1993) Quantition of the interaction of protein kinase C with diacylglycerol and phosphoinositides by time-resolved detection of resonance energy transfer. Biochemistry 32,13310-13317[Medline]
  44. Chauhan, A., Brockerhoff, H., Wininsniewski, H. M., Chauhan, V. S. P. (1991) Interaction of protein kinase C with phosphoinositides. Arch. Biochem. Biophys. 287,283-287[Medline]
  45. Woods, A., Couchman, J. R. (1998) Syndecans: synergistic activators of cell adhesion. Trends Cell Biol 8,189-192[Medline]
  46. Baciu, P. C., Goetinck, P. F. (1995) Protein kinase C regulates the recruitment of syndecan-4 into focal contacts. Mol. Biol. Cell 6,1503-1513[Abstract]
  47. Raulo, E., Chernousov, M. A., Carey, D. J., Nolo, R., Rauvala, H. (1994) Isolation of a neuronal cell surface receptor of heparin binding growth-associated molecule (HB-GAM). J. Biol. Chem. 269,12999-13004[Abstract/Free Full Text]
  48. Nolo, R., Kaksonen, M., Raulo, E., Rauvala, H. (1995) Co-expression of heparin-binding growth associated molecule (HB-GAM) and N-syndecan (syndecan-3) in developing rat brain. Neurosci. Lett. 191,39-42[Medline]
  49. Kinnunen, T., Kaksonen, M., Saarinen, J., Kalkkinen, N., Peng, H. B., Rauvala, H. (1998) Cortactin/Src-kinase signaling pathway is involved in N-syndecan-dependent neurite outgrowth. J. Biol. Chem. 273,10702-10708[Abstract/Free Full Text]
  50. Kinnunen, T., Raulo, E., Nolo, R., Maccarana, M., Lindahl, U., Rauvala, H. (1996) Neurite outgrowth in brain neurons induced by heparin-binding growth-associated molecule (HB-GAM) depends on the specific interaction of HB-GAM with heparan sulfate at the cell surface. J. Biol. Chem. 271,2243-2248[Abstract/Free Full Text]
  51. Wu, H., Reynolds, A. B., Kanner, S. B., Vines, R. R., Parson, J. T. (1991) Identification and characterization of a novel cytoskeleton-associated pp60src substrate. Mol. Cell. Biol. 11,5113-5124[Abstract/Free Full Text]
  52. Huang, C., Ni, Y., Wang, T., Gao, Y., Haudenschild, C. C., Zhan, X. (1997) Downregulation of the filamentous actin cross-linking activity of cortactin by src-mediated tyrosine phosphorylation. J. Biol. Chem. 272,13911-13915[Abstract/Free Full Text]
  53. LaVallee, M. T., Prudovsky, I. A., McMahon, G. A., Hu, X., Maciag, T. (1998) Activation of the MAP kinase pathway by FGF-1 correlates with cell proliferation induction, while activation of the src pathway correlates with migration. J. Cell Biol. 141,1647-1658[Abstract/Free Full Text]
  54. Thomas, S. M., Brugge, J. S. (1997) Cellular functions regulated by src family kinases. Annu. Rev. Cell Dev. Biol. 13,513-609[Medline]
  55. Ponting, C. P., Phillips, C., Davies, K. E., Blake, D. J. (1997) PDZ domains: targetting signalling molecules to sub-membranous sites. BioEssays 19,469-479[Medline]
  56. Fanning, A. S., Anderson, J. M. (1998) PDZ domains and the formation of protein networks at the plasma membrane. Curr. Top. Microbiol. Immunol. 228,209-233[Medline]
  57. Grootjans, J. J., Zimmermann, P., Reekmans, G., Smets, A., Degeest, G., Dürr, J., David, G. (1997) Syntenin, a PDZ protein that binds syndecan cytoplasmic domains. Proc. Natl. Acad. Sci. USA 94,13683-13688[Abstract/Free Full Text]
  58. Cohen, A. R., Wood, D. F., Marfatia, S. M., Walther, Z., Chishti, A. H., Anderson, J. M. (1998) Human CASK/LIN-2 binds syndecan-2 and protein 4.1 and localizes to the basolateral membrane of epithelial cells. J. Cell. Biol. 142,129-138[Abstract/Free Full Text]
  59. Hsueh, Y.-P., Yang, F.-C., Kharazia, V., Naisbitt, S., Cohen, A. R., Weinberg, R. J., Sheng, M. (1998) Direct interaction of CASK/LIN-2 and syndecan heparan sulfate proteoglycan and their overlapping distribution in neuronal synapses. J. Cell. Biol. 142,139-151[Abstract/Free Full Text]
  60. Bredt, D. S. (1998) Sorting out genes that regulate epithelial and neuronal polarity. Cell 94,691-694[Medline]
  61. Miettinen, H. M., Edwards, S. N., Jalkanen, M. (1994) Analysis of transport and targeting of syndecan-1: effect of cytoplasmic tail deletions. Mol. Biol. Cell 5,1325-1339[Abstract]
  62. Vaheri, A., Carpen, O., Heiska, L., Helander, T. S., Jaaskelainen, J., Majander-Nordenswan, P., Sainio, M., Timonen, T., Turunen, O. (1997) The ezrin protein family: membrane-cytoskeleton interactions and disease associations. Curr. Opin. Cell Biol. 9,659-666[Medline]
  63. Fuki, I. V., Kuhn, K. M., Lomazov, I. R., Rothman, V. L., Tuszynski, G. P., Iozzo, R. V., Swenson, T. L., Fisher, E. A., Williams, K. J. (1997) The syndecan family of proteoglycans. J. Clin. Invest. 100,1611-1622[Medline]
  64. Asundi, V. K., Carey, D. J. (1995) Self-association of N-Syndecan (Syndecan-3) core protein is mediated by a novel structural motif in the transmembrane domain and ectodomain flanking region. J. Biol. Chem. 270,26404-26410[Abstract/Free Full Text]
  65. Oh, E.-S., Couchman, J. R., Woods, A. (1997) Serine phosphorylation of syndecan-2 proteoglycan cytoplasmic domain. Arch. Biochem. Biophys. 344,67-74[Medline]
  66. Martinho, R. G., Castel, S., Urena, J., Fernandez-Borja, M., Makiya, R., Oliecrona, G., Reina, M., Alonso, A., Vilaro, S. (1996) Ligand binding to heparan sulfate proteoglycans induces their aggregation and distribution along actin cytoskeleton. Mol. Biol. Cell 7,1771-1788[Abstract]
  67. Kemp, B. E., Pearson, R. B. (1990) Protein kinase recognition sequence motifs. Trends Biochem. Sci. 15,342-346[Medline]
  68. Pawson, T. (1995) Getting down to specifics. Nature 373,477-478[Medline]
  69. Songyang, Z., Carraway, K. L., III, Eck, M. J., Harrison, S. C., Feldman, R. A., Mohammadi, M., Schlessinger, J., Hubbard, S. R., Smith, D. P., Eng, C., Lorenzo, M. J., Ponder, B. A. J., Mayer, B. J., Cantley, L. C. (1995) Catalytic specificity of protein-tyrosine kinases is critical for selective signalling. Nature 373,536-539[Medline]
  70. Asundi, V. K., Carey, D. J. (1997) Phosphorylation of recombinant N-syndecan (syndecan-3) core protein. Biochem. Biophys. Res. Commun. 240,502-506[Medline]
  71. Reiland, J., Ott, V. L., Lebakken, C. S., Yeaman, C., Mc Carthy, J., Rapraeger, A. C. (1996) Pervanadate activation of intracellular kinases leads to tyrosine phosphorylation and shedding of syndecan-1. Biochem. J. 319,39-47
  72. Prasthofer, T., Ek, B., Ekman, P., Owens, R., Hook, M., Johansson, S. (1995) Protein kinase C phosphorylates two of the four known syndecan cytoplasmic domains in vitro. Biochem. Mol. Biol. Int. 36,793-802[Medline]
  73. Itano, N., Oguri, K., Nagayasu, Y., Kusano, Y., Nakanishi, H., David, G., Okayama, M. (1996) Phosphorylation of a membrane intercalated proteoglycan, syndecan-2, expressed in a stroma-inducing clone from a mouse Lewis lung carcinoma. Biochem. J. 315,925-930
  74. Horowitz, A., Simons, M. (1998) Regulation of syndecan-4 phosphorylation in vivo. J. Biol. Chem. 273,10914-10918[Abstract/Free Full Text]
  75. Rijken, P. J., Boonstra, J., Verkleij, A. J., de Laat, S. W. (1994) Effects of gravity on the cellular response to epidermal growth factor. Adv. Space Biol. Med. 4,159-188[Medline]
  76. Hughes-Fulford, M., Lewis, M. L. (1996) Effects of microgravity on osteoblast growth activation. Exp. Cell. Res. 224,103-109[Medline]
  77. Schmitt, D. A., Hatton, J. P., Emond, C., Chaput, D., Paris, H., Levade, T., Cazenave, J-P., Schaffar, L. (1996) The distribution of protein kinase C in human leukocytes is altered in microgravity. FASEB J 10,1627-1634[Abstract]
  78. Guignandon, A., Usson, Y., Laroche, N., Lafage-Proust, M-H., Sabido, O., Alexandre, C., Vico, L. (1997) Effects of intermittent or continuous gravitational stresses on cell-matrix adhesion: quantitative analysis of focal contacts in osteoblastic ROS 17/2.8 cells. Exp. Cell Res. 236,66-75[Medline]
  79. Lewis, M. L., Reynolds, J. L., Cubano, L. A., Hatton, J. P., Lawless, B. D., Piepmeier, E. H. (1998) Spaceflight alters microtubules and increases apoptosis in human lymphocytes (Jurkat). FASEB J 12,1007-1018[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
Genes Dev.Home page
D.D.W. Cornelison, S. A. Wilcox-Adelman, P. F. Goetinck, H. Rauvala, A. C. Rapraeger, and B. B. Olwin
Essential and separable roles for Syndecan-3 and Syndecan-4 in skeletal muscle development and regeneration
Genes & Dev., September 15, 2004; 18(18): 2231 - 2236.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. S. Deepa, S. Yamada, M. Zako, O. Goldberger, and K. Sugahara
Chondroitin Sulfate Chains on Syndecan-1 and Syndecan-4 from Normal Murine Mammary Gland Epithelial Cells Are Structurally and Functionally Distinct and Cooperate with Heparan Sulfate Chains to Bind Growth Factors: A NOVEL FUNCTION TO CONTROL BINDING OF MIDKINE, PLEIOTROPHIN, AND BASIC FIBROBLAST GROWTH FACTOR
J. Biol. Chem., September 3, 2004; 279(36): 37368 - 37376.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
E. Tkachenko, E. Lutgens, R.-V. Stan, and M. Simons
Fibroblast growth factor 2 endocytosis in endothelial cells proceed via syndecan-4-dependent activation of Rac1 and a Cdc42-dependent macropinocytic pathway
J. Cell Sci., July 1, 2004; 117(15): 3189 - 3199.
[Abstract] [Full Text] [PDF]


Home page
GlycobiologyHome page
M. Hamon, E. Mbemba, N. Charnaux, H. Slimani, S. Brule, L. Saffar, R. Vassy, C. Prost, N. Lievre, A. Starzec, et al.
A syndecan-4/CXCR4 complex expressed on human primary lymphocytes and macrophages and HeLa cell line binds the CXC chemokine stromal cell-derived factor-1 (SDF-1)
Glycobiology, April 1, 2004; 14(4): 311 - 323.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
A. J. Santas, C. Bahler, J. A. Peterson, M. S. Filla, P. L. Kaufman, E. R. Tamm, D. H. Johnson, and D. M. P. Peters
Effect of Heparin II Domain of Fibronectin on Aqueous Outflow in Cultured Anterior Segments of Human Eyes
Invest. Ophthalmol. Vis. Sci., November 1, 2003; 44(11): 4796 - 4804.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
R. O. Dull, R. Dinavahi, L. Schwartz, D. E. Humphries, D. Berry, R. Sasisekharan, and J. G. N. Garcia
Lung endothelial heparan sulfates mediate cationic peptide-induced barrier dysfunction: a new role for the glycocalyx
Am J Physiol Lung Cell Mol Physiol, November 1, 2003; 285(5): L986 - L995.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Zako, J. Dong, O. Goldberger, M. Bernfield, J. T. Gallagher, and J. A. Deakin
Syndecan-1 and -4 Synthesized Simultaneously by Mouse Mammary Gland Epithelial Cells Bear Heparan Sulfate Chains That Are Apparently Structurally Indistinguishable
J. Biol. Chem., April 4, 2003; 278(15): 13561 - 13569.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. K. Greene, S. Tumova, J. R. Couchman, and A. Woods
Syndecan-4 Associates with alpha -Actinin
J. Biol. Chem., February 21, 2003; 278(9): 7617 - 7623.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. R. Couchman, S. Vogt, S.-T. Lim, Y. Lim, E.-S. Oh, G. D. Prestwich, A. Theibert, W. Lee, and A. Woods
Regulation of Inositol Phospholipid Binding and Signaling through Syndecan-4
J. Biol. Chem., December 13, 2002; 277(51): 49296 - 49303.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
E. Zamir and B. Geiger
Molecular complexity and dynamics of cell-matrix adhesions
J. Cell Sci., March 12, 2002; 114(20): 3583 - 3590.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
J. Li, N. W. Shworak, and M. Simons
Increased responsiveness of hypoxic endothelial cells to FGF2 is mediated by HIF-1{alpha}-dependent regulation of enzymes involved in synthesis of heparan sulfate FGF2-binding sites
J. Cell Sci., January 5, 2002; 115(9): 1951 - 1959.
[Abstract] [Full Text] [PDF]


Home page
Clin. Microbiol. Rev.Home page
J. A. Vazquez-Boland, M. Kuhn, P. Berche, T. Chakraborty, G. Dominguez-Bernal, W. Goebel, B. Gonzalez-Zorn, J. Wehland, and J. Kreft
Listeria Pathogenesis and Molecular Virulence Determinants
Clin. Microbiol. Rev., July 1, 2001; 14(3): 584 - 640.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
J. C. Adams, N. Kureishy, and A. L. Taylor
A Role for Syndecan-1 in Coupling Fascin Spike Formation by Thrombospondin-1
J. Cell Biol., March 19, 2001; 152(6): 1169 - 1182.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
P. Zimmermann, D. Tomatis, M. Rosas, J. Grootjans, I. Leenaerts, G. Degeest, G. Reekmans, C. Coomans, and G. David
Characterization of Syntenin, a Syndecan-binding PDZ Protein, as a Component of Cell Adhesion Sites and Microfilaments
Mol. Biol. Cell, February 1, 2001; 12(2): 339 - 350.
[Abstract] [Full Text]


Home page
BloodHome page
G. Bernardini, G. Spinetti, D. Ribatti, G. Camarda, L. Morbidelli, M. Ziche, A. Santoni, M. C. Capogrossi, and M. Napolitano
I-309 binds to and activates endothelial cell functions and acts as an angiogenic molecule in vivo
Blood, December 15, 2000; 96(13): 4039 - 4045.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
C. E. Bandtlow and D. R. Zimmermann
Proteoglycans in the Developing Brain: New Conceptual Insights for Old Proteins
Physiol Rev, October 1, 2000; 80(4): 1267 - 1290.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
K. Iba, R. Albrechtsen, B. Gilpin, C. Frohlich, F. Loechel, A. Zolkiewska, K. Ishiguro, T. Kojima, W. Liu, J. K. Langford, et al.
The Cysteine-rich Domain of Human ADAM 12 Supports Cell Adhesion Through Syndecans and Triggers Signaling Events that Lead to {beta}1 Integrin-dependent Cell Spreading
J. Cell Biol., May 29, 2000; 149(5): 1143 - 1156.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
B. L. Allen, M. S. Filla, and A. C. Rapraeger
Role of heparan sulfate as a tissue-specific regulator of FGF-4 and FGF receptor recognition
J. Cell Biol., November 26, 2001; 155(5): 845 - 858.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by ZIMMERMANN, P.
Right arrow Articles by DAVID, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by ZIMMERMANN, P.
Right arrow Articles by DAVID, G.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS